Management of stone disease
-
Upload
beverley-wilkinson -
Category
Documents
-
view
222 -
download
5
Transcript of Management of stone disease
RENAL AND UROLOGY I
Management ofstone diseaseBeverley Wilkinson
James Hall
Causes of urolithiasis
Renal and ureteric calculiC Idiopathic
C Dietary factors (e.g. low intake of fluid, high intake of purine)
C Gouty diathesis
C Metabolic anomalies (e.g. hyperparathyroidism)
C Heredity (e.g. cystinuria, xanthinuria)
C Urinary stasis: congenital (e.g. obstruction of the pelvi-ureteric
AbstractUrolithiasis is common, affecting 10% of Caucasian men. Factors affecting
stone formation can be intrinsic to the individual and are influenced by
environmental factors.
Patients presenting with loin/groin pain to the surgical team are
common and ureteric colic should be considered in this group. The rele-
vant investigations with regards to blood, urine and imaging tests to
diagnose stone disease are discussed. In addition, the absolute indica-
tions for urgent intervention are reviewed.
Treatment for ureteric stones and renal calculi includes a wide arma-
mentarium of endourological techniques including extracorporeal shock
wave lithotripsy, ureteroscopy and percutaneous nephrolithotomy, if
conservative therapy fails.
Therapy is guided by anatomical factors, stone factors, previous treat-
ment failures as well as the patient’s wishes.
Indications, contraindications and complications of the common proce-
dures are discussed.
Keywords Bladder stone; kidney stone; ureteric stone
Introduction
Urolithiasis is a disorder characterized by the presence of calculi at
any point along the urinary tract. The disease affects 1e5% of the
population in industrialized countries, with men three times more
likely to be affected than women. It has a peak incidence between
20 and 50 years of age. The lifetime risk of developing a calculus in
a Caucasian man is nearly 10% with a recurrence risk of 50% at 10
years. Table 1 outlines the possible causes of urolithiasis.
Clinical features
junction, horseshoe kidney) or stricture
C
PainChronic infection (urease-producing organisms (e.g. Proteus)
may lead to magnesium ammonium phosphate staghorn calculi
in the renal pelvis)
C Foreign bodies (ureteric stents, suture material)
C Diseased tissue (e.g. tuberculosis)
C Prolonged immobility (e.g. spinal injury, spina bifida)
Vesical calculi
C Voiding dysfunction (e.g. urethral stricture, benign prostatic
Pain is the most common presenting symptom of ureteric calculi
and is caused by obstruction and distension of the upper urinary
tract. Obstruction can occur anywhere but the three most
common sites are the pelvi-ureteric and vesicoureteric junctions,
where there is anatomical narrowing and at the pelvic brim
where the ureter crosses the iliac vessels.
Typical renal colic is characterized by an acute onset of severe
loin pain that radiates to the ipsilateral groin and scrotum in men
Beverley Wilkinson MD FRCS (Urol) is a Specialist Registrar on the North
Trent Training Programme, UK. Conflicts of interest: none declared.
James Hall FRCS (Urol) is a Consultant Urological Surgeon at the Royal
Hallamshire Hospital, Sheffield, UK. Conflicts of interest: none declared.
SURGERY 28:7 338
or labia majora in women. The patient will move about in an
attempt to relieve the pain, and unlike patients with peritonitis
will not gain relief by keeping still. Nausea and vomiting are also
commonly associated with an acute episode of ureteric colic.
Lower urinary tract symptoms
Lower urinary tract symptoms such as dysuria, suprapubic
discomfort, urgency and strangury (an unsuccessful desire to
void) are associated with bladder stones, or ureteric calculi that
are sitting at the vesicouretric junction.
Haematuria
Haematuria is present in 85% of patients with ureteric calculi and
is usually microscopic, that is detected on dipstick testing, occa-
sionally frank blood may be observed. Absence of haematuria,
though unusual, does not rule out the presence of urinary calculi.
Infection
Infection with urease-producing organisms, for example Proteus,
causes alkalinization of the urine which is a fundamental step in
the formation of magnesium ammonium phosphate stones
(struvite). Typically large staghorn calculi develop. Calcium
phosphate and matrix calculi are also associated with infection.
Recurrent urinary tract infection can be the presenting complaint
in patients with stone disease.
Infection in an obstructed system (pyonephrosis) secondary to
a ureteric stone is a urological emergency which should be
treated aggressively. The clinical presentation can vary from
asymptomatic bacteruria to fulminant sepsis. The condition can
cause permanent loss of renal function and death if unrecognized
and untreated.
hyperplasia, stenosis of the bladder neck)
C Foreign bodies (long-term urethral/suprapubic catheterization,
ureteric stents)
C Reconstructed bladder (enterocystoplasty/bladder substitution)
C Detrusor failure
Table 1
� 2010 Published by Elsevier Ltd.
RENAL AND UROLOGY I
Physical examination
Physical examination often reveals no abnormality except for
some tenderness on the affected side. Marked tenderness in the
loin is indicative of more severe infection, that is pyonephrosis.
In this scenario signs of sepsis, pyrexia, tachycardia, hypoten-
sion, may be noted. The differential diagnosis in ureteric colic is
considered in Table 2.
Laboratory investigations
Blood tests
Blood tests including a full blood count may reveal a markedly
raised leucocyte count due to infection or sepsis. Typically a mild
leucocytosis is seen as part of an acute phase response in patients
with ureteric stones. Urea and electrolytes are mandatory to
assess renal function.
Where a renal/ureteric stone is diagnosed metabolic causes
for stone formation should be sought. These include measure-
ment of serum calcium, phosphate and uric acid and levels of
parathyroid hormone if the serum calcium is raised.
Dipstick urinalysis
Dipstick urinalysis will be positive for blood in 85% of cases and
may also demonstrate leucocytes and nitrites if there is infection
present. pH may be indicative of the type of stone, acidic urine
suggests uric acid stones whilst alkaline urine is suggestive of
infection. A mid-stream urine (MSU) sample should be sent to
identify infection and urea-splitting organisms. A spot test can be
performed to identify patients with cystinuria.
Stone analysis
Stone analysis should be performed if available, as this may direct
treatment in patients who suffer from recurrent stone disease.
The chemical composition of urinary tract calculi include:
� calcium oxalate 60%
� calcium phosphate 20%
Differential diagnosis of urolithiasis
Non-urological
C Appendicitis
C Diverticulitis
C Ectopic pregnancy
C Salpingitis
C Torsion of an ovarian cyst
C Ruptured abdominal aortic aneurysm
C Biliary colic
UrologicalC Tumour
C Pyleonephritis
C Retroperitoneal fibrosis
C Stricture
C Obstruction of the pelvi-ureteric junction
C Papillary necrosis
C Renal infarction
C Testicular torsion
Table 2
SURGERY 28:7 339
� uric acid 10%
� cystine 3%
� struvite 7%.
Imaging
Non-contrast computed tomography (CT) of the kidneys,
ureters and bladder (NCCT-KUB)
Imaging for the diagnosis of ureteric colic has significantly
advanced over the last 5 years with a non-contrast CT of the
kidneys, ureters and bladder (NCCT-KUB) recommended as the
first-line investigation by the Royal College of Radiologists. Using
modern multi-slice scanners, the investigation is rapid and has
a sensitivity of 99%, (it does not detect indinavir stones). It carries
none of the risks associated with contrast media and does not
require normal renal function. In addition, in the absence of
ureteric calculi approximately 30% of CT-KUB investigations will
reveal an alternative diagnosis, for example appendicitis, diver-
ticulitis, adnexal masses, that would not have been apparent on an
intravenous urogram. However, NCCT-KUB involves 1.5 times
more radiation than a standard intravenous urogram (IVU).
Typical signs of ureteric calculi on NCCT-KUB include, fat
stranding around the kidney suggesting obstruction, proximal
hydronephrosis and hydroureter which can be traced to a stone
(Figure 1). Three-dimensional formatting can be invaluable in
complex patients with a large stone burden to plan treatment and
access to the kidney.
A plain radiograph of the kidneys, ureters and bladder
(KUBXR) must be obtained in combination with the NCCT-KUB
scan. If the stone is visible, further plain radiographs of the
kidneys, ureter and bladder can be used for follow-up; if the stone
is not visible, repeat CT scans may be needed. Only 60% of stones
are radio-opaque on plain films with uric acid being radiolucent.
Intravenous urogram
IVU has been superseded by NCCT-KUB in most units, but is occa-
sionally still used. An IVU consists of a preliminary control KUBXR
followed by an intravenous bolus injection of iodinated contrast
medium. Serial radiographs are taken at intervals of 5 minutes,
15 minutes and then culminating in a post-micturition film.
Diagnostic accuracy of an intravenous urogram approaches
90% and it gives good anatomical information of the pelvicaly-
ceal system and ureters. Some functional information can also be
obtained because excretion of the contrast requires a functional
renal unit. Obstruction is shown by a dense nephrogram and
a lack of contrast entering the collecting system. Delayed films
may be required to identify the point of obstruction. Disadvan-
tages of the IVU are that the quality of the images will be reduced
in patients with poor renal function, there is a risk of contrast
allergy, anaphylaxis and nephrotoxicity.
Intravenous contrast should be avoided in patients taking
metformin who are at risk of developing lactic acidosis.
Ultrasound
Ultrasound scanning (USS) can be used with a KUBXR as an
alternative to NCCT-KUB but at best diagnostic accuracy is only
75%. It is the first-line investigation in pregnancy. It is not
affected by the stone composition and will clarify if opacities
seen on a KUB are within the kidney. Its accuracy is operator
dependent, and it is poor at detecting stones in the ureter.
� 2010 Published by Elsevier Ltd.
Non-contrast computed tomography of the kidneys, ureters and bladder that demonstrates: a hydronephrosis of right kidney and b dilated ureter
traced to upper ureteric calculus.
Figure 1
RENAL AND UROLOGY I
Isotope renography
Isotope renography uses intravenous technetium-99 labelled
pharmaceuticals to assess different parameters of renal function.
A dynamic scan will give information with regards to function
and obstruction and for this mercaptoacetyltriglycine (MAG3) is
commonly used. A static scan uses dimercaptosuccinic acid
(DMSA) as the pharmaceutical. This gives an assessment of
‘functioning nephrons’ and values of relative (split) renal func-
tion. This is invaluable in treatment planning particularly in
those with staghorn calculi where if the relative function is less
than 15%, nephrectomy may be more appropriate for the patient.
Magnetic resonance urography
Magnetic resonance urography is rarely indicated, but is useful
in pregnancy, when ionizing radiation should be avoided. It has
an accuracy of 95% at diagnosing ureteric obstruction, but does
not visualize stones well. However it is costly, time consuming
and is not used as a routine. It should be avoided in the first
trimester.
Management of ureteric calculi
Conservative
Ureteric calculi presenting as an emergency should be given
analgesia, for example diclofenac or pethidine, and antiemetics as
required. A conservative approach can be adopted for most
ureteric stones. As a general rule the smaller and more distal the
stone the more likely it is to pass spontaneously. Stones measuring
4 mm or less will pass in about 80% of patients. However, this falls
to only 10% for stones measuring 6 mm or larger. For small stones
visible on KUB X-ray the patient can be reviewed in the outpatient
clinic in 2e4 weeks after discharge. Serial KUB X-rays will confirm
movement or passage of the stone.
Medical expulsive therapy (MET) is the use of oral medication to
try and increase the stone expulsion rate. This has been developed
from several physiological and pathophysiological observations.
SURGERY 28:7 340
The ureter is lined by smooth muscle cells that relax when there is
a decrease in calcium ion concentrations. Furthermore, smooth
muscle cells are densely populated by alpha-1-adrenoreceptors.
Blocking of these prevents ureteric spasm but allows normal
peristaltic waves. Many trials have been performed using calcium
channel blockers, alpha blockers and anti-inflammatory drugs.
Meta-analyses of pooled data analysing the use of alpha blockers
have suggested an increase of 28% in the stone expulsion rate. This
is an off licence use of the drug, and must be explained to the
patient when prescribed. The only randomized controlled study on
this does not demonstrate an increase in expulsion rate although
the use of analgesics and the time to expulsion decreased in the
treatment group. This treatment has gained popularity despite
a lack of randomized controlled trials on the topic.
Dissolution therapy can be employed with the best results
obtained in patients with uric acid stones. A combination of high
intake of fluid, urinary deacidification with high doses of potas-
sium citrate, and administration of allopurinol can lead to
dissolution of these stones.
Some stones will inevitably require intervention, which may
be absolute or relative.
Indications for Intervention: absolute indications are usually
manifested by a deterioration of the patient’s clinical condition,
that is pyonephrosis and urosepsis or worsening renal function.
In pyonephrosis, placement of a percutaneous nephrostomy
drain is the first-line treatment which is performed under USS
guidance. In the authors’ experience, this is safer and more
reliable than any form of retrograde intervention (stent place-
ment or ureteroscopy) (Figure 2). This approach also facilitates
future antegrade studies, allows antegrade stent placement and
can provide access for percutaneous stone surgery. Occasionally,
decompression will allow spontaneous passage of the stone.
Relative indications for intervention include intractable pain,
large stone, failure of progression, patient request and occupa-
tion (for example airline pilots).
� 2010 Published by Elsevier Ltd.
a Pelvic stone on kidneys, ureters and bladder X-ray and b needle puncture of the collecting system, with injection of contrast to confirm position
in pelvis prior to nephrostomy insertion.
Figure 2
RENAL AND UROLOGY I
For those patients that fail a conservative trial of passage of
ureteric calculi, the two main options for treatment are extra-
corporeal shock wave lithotripsy (ESWL) or ureteroscopy with
stone fragmentation. Percutaneous nephrolithotomy is occa-
sionally used in larger (>1 cm) upper ureteric or pelvi-ureteric
junction (PUJ) stones. These will each be considered in turn.
Extracorporeal shock wave lithotripsy (ESWL) is a commonly
used and routinely available technique for the treatment of ureteral
and renal calculi. It is usually performed as an outpatient proce-
dure and is well-tolerated requiring intramuscular analgesia. It has
comparable results to ureteroscopy particularly for proximal
stones, but multiple treatments may be required and the patient
may continue to experience symptoms during this time. If ESWL is
unsuccessful after two treatments then an alternative should be
sought.
The absolute contraindications to ESWL are:
� uncorrected coagulopathy
� urosepsis
� pregnancy
� renal artery aneurysm or aortic aneurysm.
ESWLattempts to break up the stone byusing an externally applied,
focused, high-intensity acoustic pulse. Three components to the
machine are as follows: (i) an energy source to create the shock
wave; (ii) a coupling mechanism(usually a water-filled membrane)
to transfer the energy from outside to inside the body; (iii) a guid-
ance system, usually fluoroscopy but USS can be used.
The three types of energy sources are:
Electrohydraulic e an underwater spark discharge generates
a hydrodynamic pressure wave, which is released at the focal
point of a parabolic reflector
Electromagnetic e a charge difference between two plates
will cause motion and generation of a shock wave which can
be focused by an acoustic lens.
SURGERY 28:7 341
Piezoelectric e an array of piezocrystals arranged in a semi-
circular fashion, focused at the centre of its sphere generates
peak pressures sufficient for stone fragmentation.
The successive shock wave pressure pulses result in direct
shearing forces, as well as cavitation bubbles surrounding the
stone, which fragment the stones into smaller pieces that then
can easily pass through the ureters.
After treatment most patients will have some pain that can be
controlled at home on oral analgesia, and haematuria is common.
The occasional complications after ESWL are:
� infection
� renal haemorrhage/haematoma
� adjacent organ injury
� steinstrasse (‘stone street’), a column of obstructing stone
fragments in the ureter
� possible hypertension and renal dysfunction (delayed effect).
Ureteroscopy is the examination of the ureter using a specially
designed ureteroscope. The two types of ureteroscopes in
common use are the semi-rigid and flexible ureteroscope
(Figure 3). With a single treatment the stone clearance rates are
better for ureteroscopy than for ESWL.
Indications for ureteroscopy are:
� the calculi cannot be visualized for ESWL
� calculi resistant to ESWL (for example cystine).
Semi-rigid scopes are constructed of metal and have high-density
fibreoptic bundles for both light and image transmission.
Although it is possible to advance a semi-rigid ureteroscope into
the renal pelvis, this instrument is primarily used for accessing
and fragmenting stones within the ureter.
Flexible ureteroscopes again use fibreoptic bundles but of
much smaller diameter, which increases the manoeuvrability and
permits access to all parts of the renal collecting system (including
the pelvis and the calyces). All types of ureteroscope have
� 2010 Published by Elsevier Ltd.
Figure 3 Equipment used to treat stone disease.
RENAL AND UROLOGY I
a working channel through which instruments (for example
guidewires, fragmentation devices, stone retrieval instruments)
can be passed. In order to fragment and extract calculi using
an ureteroscope, the following endoscopic lithotrites are available.
Ballistic lithotripsy: examples include the lithoclast, which uses
a direct-contact, solid, rigid probe to fragment calculi using
mechanics similar to those of a pneumatic jackhammer. The
lithoclast has a wide margin of safety.
Laser lithotripsy: a progression of laser modalities led to the
development of the holmium/YAG laser, which is a thermal laser
using light at a wavelength of 2140 nm. It acts to vaporize calculi,
producing fine dust and small particulate debris that can, in part,
be irrigated from the urinary tract during treatment. It is well
absorbed by water and urine with a penetration depth of 0.4 mm;
it therefore has minimal effect on local tissues and is very safe.
Electrohydraulic lithotripsy (EHL) was the first modality of
intracorporeal lithotripsy. An electric discharge vaporizes the
surrounding fluid, creating a cavitation bubble that impacts on
the stone. Tissue damage with this technique is common and it is
now rarely used in the ureter.
Ultrasonic lithotripsy: this utilizes the piezoelectric principle to
generate vibrational energy to create a drilling effect at the tip of the
probe. Modern ureteroscopes are too small to accommodate these
probes. This method is used in percutaneous nephrolithotomy.
Ballistic and laser lithotripsy are currently the most common
techniques used with the semi-rigid ureteroscopes. The most
effective lithotriptor for use through a small-diameter flexible
ureteroscope is the holmium/YAG laser (200 mm).
Stents after ureteroscopy
A double J stent is occasionally inserted after ureteroscopy, they
will not aid stone passage and are indicated if:
� there has been ureteric injury, or if a stricture has been
encountered and dilated
� there are residual stones that may obstruct the ureter
� there are solitary kidneys.
Percutaneous nephrolithotomy
Percutaneous nephrolithotomy (PCNL) can be used as an ante-
grade approach to large upper ureteric calculi or in patients
where access from the ureters is not possible, for example in
patients that have a loop diversion following cystectomy. This
procedure is discussed in detail in the next section.
SURGERY 28:7 342
Laparoscopic ureterolithotomy
Laparoscopic ureterolithotomy can be utilized in patients with
a large stone burden in the proximal ureter, that may require
multiple treatments to be rendered stone-free. Ureterolithomy
provides an option for stones to be removed in a single procedure
and, with the increasing experience with laparoscopy in urology,
this can be performed with low morbidity. Open surgery for
stones is rarely performed in the UK.
Renal calculi e treatment
Renal calculi
Renal calculi may present with symptoms or commonly are found
incidentally as patients are investigated for other disorders.
Presenting symptoms include:
� pain
� haematuria (microscopic, occasionally macroscopic)
� recurrent urinary tract infections
� rarely, struivite stones present with infective complications
for example pyonephrosis, perinephric abscess, xanthogra-
nulomatous pyelonephritis (XPN).
Conservative management
This should be employed in asymptomatic patients with:
� renal calculi <5 mm in diameter
� medullary sponge kidney
� stones in calyceal cysts.
Surveillance with KUB radiographs is required to monitor
progress.
ESWL
This is the recommended treatment for non-complex renal
calculi. However, stone clearance after ESWL is dramatically
reduced when the stone size exceeds 2 cm. Similarly, retreatment
and complication rates increase with larger calculi.
Certain anatomical and stone considerations can be poor
prognostic factors for successful ESWL. It is not recommended
for patients with a stone burden >2 cm, staghorn calculi, stones
associated with abnormal renal anatomy (for example pelvi-
ureteric junction (PUJ) obstruction, horseshoe kidney, calyceal
diverticulum) and cystine stones.
PCNL
PCNL is a very successful single-staged procedure for patients with
larger stones. For stones >2 cm and staghorn calculi it is the rec-
ommended treatment of choice (Figure 4). Access to an appropriate
calyx is obtained via a needle puncture under radiological guidance
that permits endoscopic access directly into the renal collecting
system and upper ureter. A guidewire is inserted to the collecting
system, over which the tract is dilated (to 30 Fr) with a pressurized
balloon or a series of graduated dilators. Once dilated, the tract is
maintained by an Amplatz sheath�, through which a nephroscope
is introduced. Fragmentation of the stone can be accomplished
using the lithotripsy techniques described above.
Following the procedure, a nephrostomy tube drain is often
left in situ and a ureteric stent may also be placed.
Complications of PCNL are:
� infection
� haemorrhage, occasionally severe requiring embolization
� pleural/lung damage (higher risk in upper-pole punctures)
� 2010 Published by Elsevier Ltd.
a Staghorn calculus on kidneys, ureters and bladder X-ray. b Large perirenal haematoma following percutaneous nephrolithotomy (PCNL).
c Selective renal embolization for bleeding post-PCNL. Coil seen in vessels.
Figure 4
RENAL AND UROLOGY I
� residual stone fragments
� renal parenchymal damage
� damage to other organs (for example colon).
Laparoscopic surgery
Laparoscopic surgery may be employed for stone removal at the
time of definitive surgery for pyeloplasty, but it is rarely used alone.
In a poorly functioning kidney containing stones, that is less
than 15% split function on a DMSA renogram, nephrectomy is
advised. This can be performed laparoscopically, but such cases
are often difficult due to scarring around the kidney.
Bladder calculi
Bladder calculi are usually a manifestation of an underlying
pathological condition, including voiding dysfunction or
a foreign body within the bladder. Most vesical calculi are seen in
men, although, in the ‘developing’ world, they are frequently
found in prepubescent boys.
A solitary bladder calculus is more commonly seen (75%)
rather than multiple stones (Figure 5). Physical examination may
reveal benign prostatic enlargement and a palpable bladder may
be evident in patients with bladder outflow obstruction. A KUB
radiograph usually confirms the diagnosis, although cystoscopy
or NCCT-KUB is a more definitive test.
Management
Figure 5 Kidneys, ureters and bladder X-ray demonstrating bladder
stones.
The most important principle in treating vesical calculi is
prevention and eradication of the underlying cause (for example
transurethral resection of the prostate (TURP) for benign pros-
tatic hyperplasia (BPH)).
Endoscopic cystolitholapaxy allows most vesical calculi to be
fragmented and subsequently irrigated/washed out through the
cystoscope. Mechanical lithotrites should be used with caution to
prevent bladder injury when the jaws are closed. These instru-
ments are used with a partially full bladder and with direct
endoscopic visualization to ensure minimal complications.
SURGERY 28:7 343
Various types of endoscopic lithotrites (for example EHL,
ballistic, holmium/YAG laser) can be employed to fragment
vesical calculi that are too large to crush with the manual
mechanical devices.
� 2010 Published by Elsevier Ltd.
RENAL AND UROLOGY I
Open suprapubic cystolithotomy is reserved for endoscopic
failures and large stones at presentation with a narrow urethra,
particularly in children.
Complications of urinary calculi
Infection
All urinary calculi may be associated with infection secondary to
obstruction and stasis.
Ipsilateral renal function deterioration
This is associated with an obstructing ureteral or renal calculus
and may occur within days. Swift renal destruction occurs with
pyonephrosis.
Tissue damage
This can lead to fibrosis and ureteric strictures.
Xanthogranulomatous pyelonephritis
This is characterized by diffuse renal parenchymal destruction.
Obstructive uropathy secondary to renal calculi is usually
involved and it is frequently misdiagnosed as a renal tumour.
Squamous cell carcinoma
This can occur in patients with a history of staghorn calculi or
bladder stones related to chronic inflammation.
SURGERY 28:7 344
Prevention of recurrence
Approximately 50% of patients experience recurrent urinary
calculi within 5 years without prophylactic intervention. Risk
factors as described previously should be identified and modi-
fied. Patients should be instructed to increase fluid intake in
order to maintain a urine output of >2 litres/day. This is prob-
ably the single most important factor in preventing recurrence. In
addition, dietary oxalate and sodium intake should be limited to
decrease the urinary excretion of oxalate and calcium. Animal
protein (meat or fish) can increase urinary excretion of calcium,
and uric acid and should be limited. Sensible advice to give to
patients in clinic is to recommend that they:
� drink enough to void pale unconcentrated urine, that is more
on a hot day
� do not add salt to food
� eat no more than a piece of meat or fish the size of the palm of
your hand in one day.
Uric acid stones can be prevented by reducing intake of animal
protein, and deacidification of the urine using potassium citrate
is useful. Allupurinol is given and titrated according to the uric
acid level.
Cysteine stone formers are a special group who require
aggressive hydration, >4 litres/day, urinary alkalinization with
potassium citrate and the use of drugs such as D-penicillamine
which make the cysteine more soluble. A
� 2010 Published by Elsevier Ltd.